What the label lists and what reports show
Methamphetamine side effects
Methamphetamine's FDA label lists its adverse reactions in its own words. FAERS holds 1,074 reports naming it through July 30, 2026; the reaction reported most often, leaving out the conditions it is used for, product-use terms and outcomes, is toxicity to various agents (268 reports).
- Generic listed
- Boxed warning
- DEA Schedule II
Check it at the source: the methamphetamine FDA label on DailyMed (effective September 30, 2024, Hikma Pharmaceuticals USA Inc.); the FDA FAERS public dashboard.
What does the patient leaflet say about side effects?
From the patient leaflet: What are possible side effects of methamphetamine hydrochloride tablets?Methamphetamine hydrochloride tablets may cause serious side effects, including: • See “ What is the most important information I should know about methamphetamine hydrochloride tablets? ” • Slowing of growth (height and weight) in children. Children should have their height and weight checked often during treatment with methamphetamine hydrochloride tablets. Methamphetamine hydrochloride tablets treatment may be stopped if your child is not growing or gaining weight. • Circulation problems in fingers and toes (peripheral vasculopathy, including Raynaud’s phenomenon). […]
Source: FDA drug label, Hikma Pharmaceuticals USA Inc., effective September 30, 2024 (SPL set 90c02ac6-e5e2-4c97-8c68-81e4e389a195), via openFDA; the full label on DailyMed
What does the label list?
From the label: adverse reactionsThe following adverse reactions are discussed in greater detail in other sections of the labeling: • Abuse, Misuse, and Addiction [see Boxed Warning, Warnings and Precautions ( 5.1 ), Drug Abuse and Dependence ( 9.2 , 9.3 )] • Hypersensitivity to amphetamine products or other ingredients of methamphetamine hydrochloride tablets [see Contraindications ( 4 )] • Hypertensive Crisis When Used Concomitantly with Monoamine Oxidase Inhibitors [see Contraindications ( 4 ), Drug Interactions ( 7.1 )] • Risks to Patient with Serious Cardiac Disease [see Warnings and Precautions ( 5.2 )] • Increased Blood Pressure and Heart Rate [see Warnings and Precautions ( 5.3 )] • Psychiatric Adverse Reactions [see Warnings and Precautions ( 5.4 )] • Long-Term Suppression of Growth in Pediatric Patients [see Warnings and Precautions ( 5.5 )] • Peripheral Vasculopathy, including Raynaud’s Phenomenon [see …
Source: FDA drug label, Hikma Pharmaceuticals USA Inc., effective September 30, 2024 (SPL set 90c02ac6-e5e2-4c97-8c68-81e4e389a195), via openFDA; the full label on DailyMed
What do FAERS reports show?
1,074 reports list methamphetamine among the medicines taken, each a report of something that happened, not proof the medicine caused it; 747 are coded as a death and 170 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is. Of the 21 reactions below, 4 are named by the same term (in US spelling) in the label's adverse reactions, warnings or patient leaflet; a reaction the label does not name may still be there under another word, and a report does not show that the medicine caused it.
Reports received each year
The 25 most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; reactions as MedDRA preferred terms
What next?
- Methamphetamine: the full record
- label, generics, price, shortages, recalls
- Report a side effect to the FDA
- MedWatch
- Side effects hub
- the most reported medicines and reactions